|
⚲
|
| D5 Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001460227 |
| Sale | 2009-03-20 ($2.5 M Offered, $1.0 M Sold) |
| Fund | |
| Phone | 6468128007 |
| Address | 401 Congress Ave Austin, 78701 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Stephen Howard | |
| Larry Witte | |
| Joe Cunningham | |
| Kevin Lalande | |
| Eric Poma |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Susan L Ciciora Trust
✚
|
0.0 | |
|
Spetzler David Baxley
✚
|
0.0 | |
|
Spessard Matthew P
✚
|
0.0 | |
|
Spethmann Jeffrey E
✚
|
0.0 | |
|
Scripps Cynthia J
✚
|
0.0 | |
|
Seyen Capital II, L.P.
✚
|
0.0 | |
|
Spexarth James W.
✚
|
0.0 | |
|
SP Fund II, a series of Safa Rashtchy Syndicates, LP
✚
|
0.0 | |
|
S&P Global Inc.
✚
|
0.0 | |
|
Supran Bryan
✚
|
0.0 |